|
Market Closed -
Nasdaq
21:00:00 13/02/2026 GMT
|
5-day change
|
1st Jan Change
|
|
196.52 USD
|
+0.52%
|
 |
-2.32%
|
+11.67%
|
|
02-12 |
Analyst recommendations: Pfizer, Applovin, Biogen, Hilton, Snap…
|  | |
02-10 |
Mizuho Raises Price Target on Biogen to $236 From $207, Keeps Outperform Rating
|
MT
| |
02-09 |
Biogen Sales Execution, Growth Support Long-Term EPS, RBC Says
|
MT
| |
02-09 |
Wedbush Raises Price Target on Biogen to $187 From $178, Keeps Neutral Rating
|
MT
| |
02-09 |
HC Wainwright Adjusts Price Target on Biogen to $228 From $194, Maintains Buy Rating
|
MT
| |
02-09 |
RBC Raises Price Target on Biogen to $233 From $217, Keeps Outperform Rating
|
MT
| |
02-09 |
Morgan Stanley Raises Price Target on Biogen to $190 From $156, Keeps Equalweight Rating
|
MT
| |
02-09 |
Bernstein Adjusts Price Target on Biogen to $201 From $191, Maintains Market Perform Rating
|
MT
| |
02-09 |
Piper Sandler Adjusts Price Target on Biogen to $177 From $157, Maintains Neutral Rating
|
MT
| |
02-09 |
Citigroup Adjusts Price Target on Biogen to $215 From $185, Maintains Neutral Rating
|
MT
| |
02-09 |
Guggenheim Adjusts Price Target on Biogen to $246 From $185, Maintains Buy Rating
|
MT
| |
02-09 |
TD Cowen Adjusts Price Target on Biogen to $215 From $175, Maintains Buy Rating
|
MT
| |
02-09 |
Analyst recommendations: Align, Take-Two, Biogen, PayPal, Stellantis…
| | |
02-06 |
Stifel Nicolaus Adjusts Biogen PT to $214 From $202, Maintains Buy Rating
|
MT
| |
02-03 |
Bernstein Adjusts Biogen Price Target to $191 From $197
|
MT
| |
01-30 |
Oppenheimer Adjusts Biogen Price Target to $225 From $205, Maintains Outperform Rating
|
MT
| |
01-30 |
Oppenheimer Raises Price Target on Biogen to $225 From $205, Keeps Outperform Rating
|
MT
| |
01-27 |
Citigroup Adjusts Price Target on Biogen to $185 From $180, Maintains Neutral Rating
|
MT
| |
01-23 |
Wedbush Raises Price Target on Biogen to $178 From $143, Keeps Neutral Rating
|
MT
| |
01-20 |
RBC Trims Price Target on Biogen to $217 From $220, Keeps Outperform Rating
|
MT
| |
01-09 |
Bernstein Adjusts Price Target on Biogen to $197 From $157, Maintains Market Perform Rating
|
MT
| |
01-08 |
Goldman Sachs Adjusts Price Target on Biogen to $225 From $197, Maintains Buy Rating
|
MT
| |
01-08 |
Mizuho Raises Price Target on Biogen to $207 From $177, Keeps Outperform Rating
|
MT
| |
01-08 |
RBC Raises Price Target on Biogen to $220 From $210, Keeps Outperform Rating
|
MT
| |
01-07 |
UBS Adjusts Price Target on Biogen to $185 From $130, Maintains Neutral Rating
|
MT
|
No results for this search Select your edition All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
| 
